Updated ATAGI 2023 COVID-19 booster advice

The Australian Technical Advisory Group on Immunisation (ATAGI) has released updated recommendations for an additional COVID-19 vaccine dose for highest risk people in 2023. These recommendations are in addition to the previous ATAGI COVID-19 vaccine booster advice published in February 2023.

ATAGI recommends that all adults aged ≥ 75 years should receive an additional 2023 COVID-19 vaccine dose if 6 months have passed since their last dose.

Consider an additional dose if 6 months has passed since your last dose.

Discuss with your doctor.

• Adults aged 65 to 74 years
• Those aged 18 to 64 years who are severely immunocompromised

ATAGI continues to encourage all adults who were recommended to have a COVID-19 vaccine dose in February 2023, and who have not yet had one, to receive a vaccine dose as soon as possible.

Lockridge Medical Centre is offering the following COVID-19 vaccinations:

Pfizer/Comirnaty

Primary Adult vaccinations for 12 year old and over 2 doses 3-6 weeks apart

https://www.health.gov.au/resources/publications/covid-19-vaccination-information-on-comirnaty-pfizer-covid-19-vaccinePrimary

Child vaccinations for 5-11 year olds 2 doses 8 weeks apart

https://www.health.gov.au/resources/publications/covid-19-vaccination-pfizer-information-and-consent-form-for-parents-and-guardians-of-children-aged-5-to-11-years

Novavax

Novavax has been approved as a primary vaccine for COVID vaccination for individuals 18 and over given 2 doses 3 weeks apart.

https://www.health.gov.au/resources/publications/covid-19-vaccination-information-on-nuvaxovid-novavax-covid-19-vaccine